54 Relationship between rate of percent predicted FEV1 (ppFEV1 ) decline and baseline and acute change in ppFEV1 in patients (pts) with cystic fibrosis (CF) treated with lumacaftor/ivacaftor (LUM/IVA)
Konstan, M.W, McKone, E.F, Moss, R.B, Lubarsky, B, Rubin, J, Millar, S.J, Pasta, D.J, Mayer-Hamblett, N, Goss, C.H, Morgan, W, Sawicki, G.S
Published in Journal of cystic fibrosis (01.06.2017)
Published in Journal of cystic fibrosis (01.06.2017)
Get full text
Journal Article
Design and powering of cystic fibrosis clinical trials using rate of FEV1 decline as an efficacy endpoint
Konstan, M.W, Wagener, J.S, Yegin, A, Millar, S.J, Pasta, D.J, VanDevanter, D.R
Published in Journal of cystic fibrosis (01.09.2010)
Published in Journal of cystic fibrosis (01.09.2010)
Get full text
Journal Article
Design and powering of cystic fibrosis clinical trials using pulmonary exacerbation as an efficacy endpoint
VanDevanter, D.R, Yegin, A, Morgan, W.J, Millar, S.J, Pasta, D.J, Konstan, M.W
Published in Journal of cystic fibrosis (01.12.2011)
Published in Journal of cystic fibrosis (01.12.2011)
Get full text
Journal Article
Formation of Dityrosine Cross-Links during Breadmaking
Rodriguez-Mateos, Ana, Millar, Sam J, Bhandari, Dhan G, Frazier, Richard A
Published in Journal of agricultural and food chemistry (05.04.2006)
Published in Journal of agricultural and food chemistry (05.04.2006)
Get full text
Journal Article
Genomic cloning, physical mapping, and expression of human type 2 cystatin genes
Dickinson, D P, Thiesse, M, Dempsey, L D, Millar, S J
Published in Critical reviews in oral biology and medicine (01.01.1993)
Published in Critical reviews in oral biology and medicine (01.01.1993)
Get full text
Journal Article